DNA Methylation Biomarkers Predict Progression-Free and Overall Survival of Metastatic Renal Cell Cancer (mRCC) Treated with Antiangiogenic Therapies

por Peters, Inga, Dubrowinskaja, Natalia, Abbas, Mahmoud, Seidel, Christoph, Kogosov, Michael, Scherer, Ralph, Gebauer, Kai, Merseburger, Axel S., Kuczyk, Markus A., Grünwald, Viktor, Serth, Jürgen
Publicado 2014

Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response

por Dubrowinskaja, Natalia, Gebauer, Kai, Peters, Inga, Hennenlotter, Jörg, Abbas, Mahmoud, Scherer, Ralph, Tezval, Hossein, Merseburger, Axel S, Stenzl, Arnulf, Grünwald, Viktor, Kuczyk, Markus A, Serth, Jürgen
Publicado 2014

GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma

por PETERS, INGA, GEBAUER, KAI, DUBROWINSKAJA, NATALIA, ATSCHEKZEI, FARANAZ, KRAMER, MARIO W., HENNENLOTTER, JOERG, TEZVAL, HOSSEIN, ABBAS, MAHMOUD, SCHERER, RALPH, MERSEBURGER, AXEL S., STENZL, ARNULF, KUCZYK, MARKUS A., SERTH, JUERGEN
Publicado 2014